Charles Williams
Vermögen: 401 579 $ am 31.08.2026
Vermögen: 401 579 $ am 31.08.2026
Charles Williams is Secretary & Chief Operating Officer at Surrozen, Inc. since 2025.
Formerly, Mr. Williams was Head-Corporate Development at Jazz Pharmaceuticals Plc from 2013 to 2020 and Director-Corporate & Business Development at MAP Pharmaceuticals LLC from 2008 to 2013.
Mr. Williams completed undergraduate education at Cornell University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SURROZEN INC 0.16% | 15.06.2026 | 18’237 ( 0.16% ) | 401 579 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SURROZEN, INC. | Geschäftsführer | 01.02.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01.11.2020 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Corporate Officer/Principal | 01.01.2013 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Surrozen, Inc.
Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen